Skip to main content
. 2022 Dec 8;43(1):14–27. doi: 10.1002/pd.6275

FIGURE 4.

FIGURE 4

Study structure and enrollment. AFS, Amniocentesis; cEVTs, circulating Extravillous Trophoblasts; cfDNA, high risk cell‐free DNA test; CMA, chromosomal microarray analysis; CVS, Chorionic Villus Sampling; FCT, High‐risk First trimester Combined Test; NGS, Next‐Generation Sequencing.